Maintenance Capecitabine for High-Risk Gastrointestinal Tumors: Everything That’s Old Is New Again

Por Raftery, Laura, O’Neil, Bert H.
Publicado em 2009

Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?

Por Lee, Michael S., O’Neil, Bert H.
Publicado no J Gastrointest Oncol (2016)

Using Molecular Markers to Guide Therapy of Metastatic Colorectal Cancer

Por McRee, Autumn, O'Neil, Bert H.
Publicado no J Oncopathol (2013)

Hepatocelluar Carcinoma Associated With Attenuated Familial Adenomatous Polyposis: A Case Report and Review of the Literature

Por Li, Mingqing, Gerber, David A., Koruda, Mark, O’Neil, Bert H.
Publicado em 2011

Mental Health Outcomes during Colorectal Cancer Survivorship: A Review of the Literature

Por Mosher, Catherine E., Winger, Joseph G., Given, Barbara A., Helft, Paul R., O’Neil, Bert H.
Publicado no Psychooncology (2015)

Sorafenib Effectiveness in Advanced Hepatocellular Carcinoma

Por Sanoff, Hanna K., Chang, YunKyung, Lund, Jennifer L., O’Neil, Bert H., Dusetzina, Stacie B.
Publicado no Oncologist (2016)

Everolimus and Pasireotide for Advanced and Metastatic Hepatocellular Carcinoma

Por Sanoff, Hanna K., Kim, Richard, Ivanova, Anastasia, Alistar, Angela, McRee, Autumn J., O'Neil, Bert H.
Publicado no Invest New Drugs (2015)

Detection of Shared MHC-Restricted Human Melanoma Antigens after Vaccinia Virus-Mediated Transduction of Genes Coding for HLA

Por O’Neil, Bert H., Kawakami, Yutaka, Restifo, Nicholas P., Bennink, Jack R., Yewdell, Jonathan W., Rosenberg, Steven A.
Publicado em 1993

Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts

Por Lipner, Matthew B., Marayati, Raoud, Deng, Yangmei, Wang, Xianxi, Raftery, Laura, O’Neil, Bert H., Yeh, Jen Jen
Publicado no PLoS One (2016)

NF-κB and Bcl-3 Activation Are Prognostic in Metastatic Colorectal Cancer

Por Puvvada, Soham D., Funkhouser, William K., Greene, Kevin, Deal, Allison, Chu, Haitao, Baldwin, Albert S., Tepper, Joel E., O'Neil, Bert H.
Publicado em 2010

Phase II Study of Capecitabine, Oxaliplatin, and Cetuximab for Advanced Hepatocellular Carcinoma

Por Sanoff, Hanna K., Bernard, Stephen, Goldberg, Richard M., Morse, Michael A., Garcia, Reynaldo, Woods, Lynna, Moore, Dominic T., O'Neil, Bert H.
Publicado em 2011

Family Caregiving Challenges in Advanced Colorectal Cancer: Patient and Caregiver Perspectives

Por Mosher, Catherine E., Adams, Rebecca N., Helft, Paul R., O’Neil, Bert H., Shahda, Safi, Rattray, Nicholas A., Champion, Victoria L.
Publicado no Support Care Cancer (2015)

Positive Changes among Patients with Advanced Colorectal Cancer and their Family Caregivers: A Qualitative Analysis

Por Mosher, Catherine E., Adams, Rebecca N., Helft, Paul R., O'Neil, Bert H., Shahda, Safi, Rattray, Nicholas A., Champion, Victoria L.
Publicado no Psychol Health (2016)

T-Cell Recognition of Human Melanoma Antigens

Por Kawakami, Yutaka, Nishimura, Michael I., Restifo, Nicholas P., Topalian, Suzanne L., O’Neil, Bert H., Shilyansky, Joel, Yannelli, John R., Rosenberg, Steven A.
Publicado em 1993

Subcutaneous Metastatic Adenocarcinoma: An Unusual Presentation of Colon Cancer – Case Report and Literature Review

Por Llaguna, Omar H., Desai, Payal, Fender, Anne B., Zedek, Daniel C., Meyers, Michael O., O'Neil, Bert H., Diaz, Luis A., Calvo, Benjamin F.
Publicado em 2010

A two-cohort phase 1 study of weekly oxaliplatin and gemcitabine, then oxaliplatin, gemcitabine and erlotinib during radiotherapy for unresectable pancreatic carcinoma

Por Raftery, Laura, Tepper, Joel E, Goldberg, Richard M., Blackstock, A. William, Aklilu, Mebea, Bernard, Stephen A., Ivanova, Anastasia, Davies, Janine M., O’Neil, Bert H.
Publicado em 2013

Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy

Por Davies, Janine M, Trembath, Dimitri, Deal, Allison M, Funkhouser, William K, Calvo, Benjamin F, Finnegan, Timothy, Weck, Karen E, Tepper, Joel E, O'Neil, Bert H
Publicado em 2011

A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors

Por McRee, Autumn J., Davies, Janine M., Sanoff, Hanna G., Goldberg, Richard M., Bernard, Stephen, Dees, E. Claire, Keller, Kimberly, Ivanova, Anastasia, O'Neil, Bert H.
Publicado no Cancer Chemother Pharmacol (2014)

A Phase I and Pharmacologic Study of the Combination of Bortezomib and Pegylated Liposomal Doxorubicin in Patients with Refractory Solid Tumors

Por Dees, E. Claire, O'Neil, Bert H., Lindley, Celeste M., Collichio, Frances, Carey, Lisa A., Collins, Jason, Riordan, William J., Ivanova, Anastasia, Esseltine, Dixie, Orlowski, Robert Z.
Publicado no Cancer Chemother Pharmacol (2008)

Use Of Yttrium-90 Microspheres In Patients With Advanced Hepatocellular Carcinoma & Portal Vein Thrombosis

Por Tsai, Andrea L., Burke, Charles T., Kennedy, Andrew S., Moore, Dominic T., Mauro, Matthew A., Dixon, Robert D., Stavas, Joseph M., Bernard, Stephen A., Khandani, Amir H., O'Neil, Bert H.
Publicado em 2010